Latest Us Manufacturing News

Global Laser Enrichment, Silex’s exclusive licensee, has completed large-scale uranium enrichment testing, advancing the SILEX technology closer to commercial deployment in the US nuclear fuel market.

Orbital Corporation Limited posted a $4.3 million net loss for FY25, reflecting a revenue decline amid production transitions. The company secured a $3 million capital raise to support new UAV engine development and expand its global footprint.

Orbital Corporation reveals a strategic pivot amid evolving US drone policies, with a new management team driving growth beyond Boeing Insitu. FY25 guidance shows revenue decline but promising new contracts.

Telix Pharmaceuticals reported a robust 63% year-over-year revenue increase in H1 2025, driven by strong sales of its precision medicine products and strategic acquisitions. The company is advancing multiple late-stage clinical trials and expanding its global manufacturing footprint.

Titomic has launched a major US manufacturing hub in Alabama, secured key defense contracts, and expanded leadership to accelerate its global additive manufacturing ambitions.

AML3D Limited reports a 77% jump in US customer receipts and secures a pivotal US Navy Letter of Intent worth up to $200 million, underpinning its rapid expansion in defence manufacturing.

DroneShield is investing $13 million to significantly expand its R&D and manufacturing footprint, aiming to boost annual production capacity nearly fivefold by the end of 2026.

AML3D has received a pivotal Letter of Intent from the US Navy, outlining plans for additive manufacturing collaboration and significant demand growth through 2030.

EZZ Life Science has launched its US-focused brand EZZDAY with four FDA-registered supplements, marking a major step in its international growth strategy. The company has also begun US-based manufacturing and opened an online store to target American consumers.

Clarity Pharmaceuticals has partnered with SpectronRx to manufacture and distribute its lead prostate cancer diagnostic, Cu-64 SAR-bisPSMA, at commercial scale across the US. This agreement sets the stage for a seamless launch pending FDA approval.

Reliance Worldwide Corporation updates on the financial impact of new US tariffs, outlining a multi-pronged mitigation strategy and revising its FY25 sales outlook amid market uncertainty.

Fluence Corporation reported a robust Q1 2025 with revenue surging 64.5% year-over-year, driven by the Ivory Coast Addendum project, while EBITDA turned positive for the first time in over a year. The company maintains its full-year guidance despite tariff uncertainties.